Nebula Research & Development LLC Guardant Health, Inc. Transaction History
Nebula Research & Development LLC
- $464 Billion
- Q1 2024
A detailed history of Nebula Research & Development LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 70,328 shares of GH stock, worth $2.03 Million. This represents 0.31% of its overall portfolio holdings.
Number of Shares
70,328
Previous 20,073
250.36%
Holding current value
$2.03 Million
Previous $543 Million
167.21%
% of portfolio
0.31%
Previous 0.16%
Shares
4 transactions
Others Institutions Holding GH
# of Institutions
309Shares Held
110MCall Options Held
2.51MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA11.4MShares$330 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11MShares$318 Million0.01% of portfolio
-
Baillie Gifford & CO6.23MShares$180 Million0.1% of portfolio
-
Deep Track Capital, LP Greenwich, CT6MShares$173 Million4.09% of portfolio
-
Cadian Capital Management, LP New York, NY5.79MShares$167 Million4.28% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $2.95B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...